Close Menu

In the Proceedings of the National Academy of Sciences this week, Yale University scientists have developed a cheap, microfluidic platform that uses biocompatible ferrofluids "for the controlled manipulation and rapid separation of both microparticles and live cells." Using microspheres, they achieved 99 percent separation efficiency based on size at less than 10-micron resolution, demonstrating the platform's potential in "significantly reducing incubation times and increasing diagnostic sensitivity in cellular assays

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.